Listed

Replimune Group, Inc.: Form 10-Q for the period ended Jun 30, 2022

Filed with the SEC on Aug 4, 2022 and accepted by EDGAR at Aug 4, 2022, 08:13 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2022-04-01 to 2022-06-30$29.5mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2022-04-01 to 2022-06-30−$40.9mus-gaap:OperatingIncomeLoss
Net income3 months2022-04-01 to 2022-06-30−$42.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-04-01 to 2022-06-30−$0.78us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-04-01 to 2022-06-30−$0.78us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-04-01 to 2022-06-3054,211,446 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2022-04-01 to 2022-06-30−$33.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2022-04-01 to 2022-06-30$1.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2022-06-30$112.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-06-30$401.9mus-gaap:AssetsCurrent
Total assetsAt period end2022-06-30$459.4mus-gaap:Assets
Current liabilitiesAt period end2022-06-30$20.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-06-30$49.2mus-gaap:Liabilities
Shareholders' equityAt period end2022-06-30$410.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001737953-22-000014. Last ingested by Listed: Nov 11, 2026, 01:43 ET. Listed shows no prices and gives no investment advice.